|
|
||||||||
Cutting Edge |
Servicio de Inmunología, Hospital de la Princesa, Universidad Autónoma de Madrid, Madrid, Spain
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
CD81 is a member of the tetraspanin superfamily of proteins that have been implicated in several cellular functions as cell growth, differentiation, intercellular cell adhesion, motility, and intracellular signaling (3, 4, 5). All of these functions seem to relate to the capacity of tetraspanins to form complexes with other cell surface receptors, including integrins, Ig proteins, and other tetraspanins (3, 4). Thus, CD81 physically associates with CD4 and CD8 (6) and provides a costimulatory signal in T cells (7). On B cells, CD81 associates with CD19 and CD21 to form the B cell coreceptor (8) and with MHC class II molecules in APCs (9). Recently, it has been proposed that tetraspanins form microdomains with MHC class II molecules that facilitate Ag presentation (10). Moreover, CD81 promotes T-B cell collaboration by activating LFA-1 integrin (11). Although CD81-deficient mice exhibit normal maturation of all lymphoid cells, they show a decreased Ab production in response to protein Ags (12, 13). Hence, chimeric mice in which only B cells lacked CD81 have reduced Ab production upon exposure to a Th2 stimulus (14). Lately, it has been reported that CD81-/- TCR-transgenic T cells show a diminished synthesis of IL-4 when activated by CD81+/+ B cells. In contrast, CD81-/- B cells are able to induce normal levels of IL-4 synthesis by CD81+/+ T cells (15). All of these data strongly suggest that CD81 has an important role in T-APC interaction. However, the dynamic behavior of CD81 during the formation and establishment of the IS has not been addressed yet. We report herein that CD81 localizes at the c-SMAC, as determined by three-dimensional (3D) confocal microscopy analyses. Moreover, transient transfections of CD81-green fluorescent protein (GFP) in APCs and T cells revealed that both cell types contributed to the clustering of CD81 at the central area of the IS. These data implicate CD81 in the IS and would explain the CD81-deficient mouse phenotype.
| Materials and Methods |
|---|
|
|
|---|
The Jurkat-derived human T cell line
V
8+ J77cl20 and the lymphoblastoid B cell line
Raji (16), have been previously described. Murine Th cell
clone SR.D10 and the I-Ak-transgenic B lymphoma
cell line TAK (17) were kindly provided by Dr. J. M.
Rojo (Centro de Investigaciones Biológicas-Consejo
Superior de Investigaciones Cientificas, Madrid, Spain). Human
monocyte-derived dendritic cells (DC) were generated as described
elsewhere (16) and matured with LPS (10 ng/ml)
(Sigma-Aldrich, St. Louis, MO) for 36 h. The S3085B (S3) human
cell clone was isolated from polyclonal superantigen staphylococcal
enterotoxin B (SEB)-specific primary T cells (16).
The following mAbs were used: T3b (anti-CD3), TP1/40 (anti-CD11a), and D3/9 (anti-CD45). I33.22 (anti-CD81) was kindly provided by Dr. R. Vilella (Hospital Clinic, Barcelona, Spain), FN1 by Dr. S. Funderud (Norwegian Radium Hospital, Oslo, Norway), anti-giantin by Dr. G. Egea (IDIBAPS, Universidad de Barcelona, Spain), and rat anti-mouse ICAM-1 by Dr. D. Vestweber (University of Munich, Munich, Germany). Anti-mouse CD81 (Eat2) and anti-mouse CD3 (2C11) were purchased from BD PharMingen (San Diego, CA). DCIS 1/21 (anti-MHC class II) was generated in our laboratory. Secondary Alexa 488- and Rodamine Red X-labeled Abs, streptavidin, and fluorescent trackers chloromethyl derivative of aminocoumarin (CMAC) and chloromethyl-benzoylamino-tetramethylrhodamine (CM-TMR) were obtained from Molecular Probes (Eugene, OR). Biotin-conjugated anti-hamster IgG was purchased from BD PharMingen. Recombinant human fibronectin (FN), poly-L-lysine (PLL), and superantigen staphylococcal enterotoxin E (SEE) were obtained from Toxin Technology (Sarasota, FL).
CD81-GFP construct and transient transfections
CD81-GFP was obtained by PCR amplification of the human CD81 cDNA (a gift from Dr. S. Levy, Stanford University Medical Center, Stanford, CA) and cloned in the pEGFP-N1 vector (Clontech Laboratories, Palo Alto, CA). Raji or Jurkat cells were resuspended at 2 x 107 cell/ml in Optimem-1 (Life Technologies, Grand Island, NY) with 10 µg of pEGFP-N1-CD81 and electroporated at 1200 µF/250 V in a Gene Pulser II (Bio-Rad, Hercules, CA).
Conjugate formation and immunofluorescence microscopy
To distinguish APCs from T lymphocytes, they were alternatively
loaded with the fluorescent tracker CMAC (10 µM). APCs were incubated
for 20 min at 37°C with 2 µg/ml SEE (Raji) or 1 µg/ml SEB (DC) or
for 16 h with 1 mg/ml conalbumin (TAK; Sigma-Aldrich). Jurkat, S3
T cells, and SR.D10 (105 cells) were mixed with
Raji cells (105 cells), DC (5 x
104 cells), or TAK (105
cells), respectively, and incubated for 15 min at 37°C. Cells were
plated onto PLL (50 µg/ml)- or FN (20 µg/ml)-coated slides,
incubated for 30 min at 37°C, and fixed in 4% formaldehyde. For
immunofluorescence assays, samples were blocked with TNB (0.1 M
Tris-HCl, 0.15 M NaCl, 0.5% blocking reagent; Boehringer Mannheim,
Mannheim, Germany) and FcR were blocked with human
-globulin (100
µg/ml; Sigma-Aldrich) or mouse serum (Sigma-Aldrich). After staining
with primary mAb followed by an Alexa 488-labeled specific secondary
Ab, samples were examined with a DMR photomicroscope (Leica, Mannheim,
Germany) using Leica QFISH 1.0 software. For double staining, cells
were incubated with the primary Ab followed by a goat anti-mouse
Rhodamine Red X, saturated with mouse serum, and incubated with the
biotinylated anti-CD81 and streptavidin-Alexa Fluor 488. Series of
optical sections were obtained with a Leica TCS-SP confocal scanning
laser microscope. 3D reconstructions of confocal sections (distanced
0.3 µm in the vertical axis) were assembled using Leica confocal
software.
Time-lapse fluorescence confocal microscopy
Raji or Jurkat cells (6 x 105) transiently transfected with CD81-GFP in HBSS with 2% FCS were allowed to adhere on FN-coated coverslips. The other cell type (2 x 105), previously loaded with 5 µM CM-TMR was added to the chamber. Cells were maintained at 37°C in 5% CO2, and confocal images were acquired using the Leica TCS-SP confocal microscope. Confocal series of fluorescence and the differential interference contrast (DIC) images were simultaneously obtained. The maximal projection of the most representative sections of the green channel (GFP signal), the corresponding DIC image, and the red channel image (CM-TMR signal) were overlaid in a single image.
| Results and Discussion |
|---|
|
|
|---|
It has been proposed that CD81 plays an important role in T-B cell
collaboration, since CD81-deficient mice display altered humoral immune
responses (13) and Abs against CD81 promote the formation
of T-B cell conjugates (11). To address the involvement of
CD81 in the interaction between T cells and APCs, we studied the
localization of CD81 during IS formation. We first assessed the
distribution of CD81 in a T-B cell interaction model that rendered
functional IS (16). Raji B cells pulsed or not with SEE
superantigen were conjugated for 10 min with
V
8+ Jurkat T cells. CD81, which was
homogeneously distributed in conjugates formed in the absence of SEE,
localized in a discrete central cluster at the IS in the presence of
SEE (Fig. 1
, a and
b). Likewise, CD3 was concentrated at the T-B cell contact
area when conjugates were formed in the presence of SEE (Fig. 1
, a and b). In contrast, CD45 was
homogeneously distributed throughout the plasma membrane
in these conjugates. (Fig. 1
a
and the quantitative estimation in Table I
).
|
|
Finally, the localization of this tetraspanin was examined in the
murine T cell line SR.D10 that recognizes a peptide of conalbumin
presented by a I-Ak-transgenic B cell line (TAK)
(17). In these peptide-driven cell conjugates, CD81 also
localized in a discrete cluster in the center of the interaction (Fig. 1
c and Table I
). As expected, CD3 is localized in the center
of the IS, ICAM-1 is segregated to the periphery of the contact, and
CD45 is homogeneously distributed. Together, these data demonstrate
that CD81 localizes at the IS in an Ag-dependent manner.
Segregation of CD81 at the c-SMAC
The precise localization of CD81 within the IS topography was
determined by confocal microscopy in SEE-dependent Jurkat-Raji cell
conjugates. As shown in Fig. 2
, CD81
colocalized with CD3 at the c-SMAC. The fluorescence intensity of CD81
in the IS was
20-fold higher than the rest of the T cell or APC
membrane fluorescence (Table II
). LFA-1
accumulated in the p-SMAC of the IS surrounding the c-SMAC containing
CD81 (Fig. 2
and Table II
). Both B cell-B cell homotypic and T cell-B
cell heterotypic interactions were observed, but only in the latter
conjugates was CD81 concentrated at the contact area partially
colocalizing with MHC class II molecules. Remarkably, the FN1
determinant that recognizes a subset of MHC class II molecules
associated with different tetraspanins (10), only
colocalized with CD81 in the c-SMAC (Fig. 2
and Table II
). CD45 was
excluded from the contact area in these conjugates. These results
indicate that CD81 redistributes to the contact area, and it is mainly
localized at the center of the IS, colocalizing with CD3.
|
|
Both Raji and Jurkat cells express high levels of CD81 as
determined by flow cytometry analysis (data not shown). Thus, staining
of endogenous CD81 did not allow discrimination of the cellular source
of CD81 localized at the IS. Therefore, we performed experiments with T
cells or APCs that transiently expressed CD81-GFP. In transfected Raji
or Jurkat cells, a large amount of the total GFP fusion protein was
retained intracellularly in the Golgi apparatus, as determined by
costaining with giantin, a Golgi-specific protein (data not shown).
These data concur with previous reports showing tetraspanin
localization in internal vesicles (19). Plasma membrane
CD81-GFP transfected in Jurkat cells colocalized with CD3 at the
cell-cell contact area (Fig. 3
a). In addition, Golgi
apparatus containing intracellular CD81-GFP was translocated to the IS
proximity (Fig. 3
a). The clustering of plasma membrane
CD81-GFP at the c-SMAC is only distinguishable before the vesicular
structures localized in close apposition to the IS. A total of 92% of
conjugates on which CD3 localized into the c-SMAC also displayed the T
cell-CD81-GFP translocated to the IS. The dynamics of CD81-GFP during
the T cell-APC interaction was determined by time-lapse confocal
fluorescence videomicroscopy. At the T cell side, CD81-GFP immediately
concentrated on the plasma membrane at the T cell contact area with the
APC (Fig. 3
b). Within the first 10 min, Golgi apparatus
translocated to the contact zone, where it remained along the time
tested (2 h; Fig. 3
b).
|
|
| Acknowledgments |
|---|
| Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Francisco Sánchez-Madrid, Hospital de la Princesa, Diego de León 62, 28006 Madrid, Spain. E-mail address: fsanchez{at}hlpr.insalud.es ![]()
3 Abbreviations used in this paper: IS, immune synapse; c-SMAC, central supramolecular activation complex; CMAC, chloromethyl derivative of aminocoumarin; CM-TMR, chloromethyl-benzoylamino-tetramethylrhodamine; DC, dendritic cell; DIC, differential interference contrast; FN, fibronectin; GFP, green fluorescent protein; p-SMAC, peripheral SMAC; PLL: poly-L-lysine; SEB, staphylococcal enterotoxin B; SEE, staphylococcal enterotoxin E; 3D, three dimensional. ![]()
Received for publication July 23, 2002. Accepted for publication October 25, 2002.
| References |
|---|
|
|
|---|
chain variable domain. Cell 69:999.[Medline]
1 integrins. J. Biol. Chem. 276:25005.This article has been cited by other articles:
![]() |
G. P. Coffey, R. Rajapaksa, R. Liu, O. Sharpe, C.-C. Kuo, S. W. Krauss, Y. Sagi, R. E. Davis, L. M. Staudt, J. P. Sharman, et al. Engagement of CD81 induces ezrin tyrosine phosphorylation and its cellular redistribution with filamentous actin J. Cell Sci., September 1, 2009; 122(17): 3137 - 3144. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mittelbrunn, G. M. del Hoyo, M. Lopez-Bravo, N. B. Martin-Cofreces, A. Scholer, S. Hugues, L. Fetler, S. Amigorena, C. Ardavin, and F. Sanchez-Madrid Imaging of plasmacytoid dendritic cell interactions with T cells Blood, January 1, 2009; 113(1): 75 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Brazzoli, A. Bianchi, S. Filippini, A. Weiner, Q. Zhu, M. Pizza, and S. Crotta CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes J. Virol., September 1, 2008; 82(17): 8316 - 8329. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Serra, S. Nuti, S. Tavarini, C. Sammicheli, D. Rosa, G. Saletti, E. Soldaini, S. Abrignani, and A. Wack Coligation of the Hepatitis C Virus Receptor CD81 with CD28 Primes Naive T Lymphocytes to Acquire Type 2 Effector Function J. Immunol., July 1, 2008; 181(1): 174 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Munoz, M. Mittelbrunn, H. de la Fuente, M. Perez-Martinez, A. Garcia-Perez, A. Ariza-Veguillas, F. Malavasi, M. Zubiaur, F. Sanchez-Madrid, and J. Sancho Antigen-induced clustering of surface CD38 and recruitment of intracellular CD38 to the immunologic synapse Blood, April 1, 2008; 111(7): 3653 - 3664. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Jolly and Q. J. Sattentau Human Immunodeficiency Virus Type 1 Assembly, Budding, and Cell-Cell Spread in T Cells Take Place in Tetraspanin-Enriched Plasma Membrane Domains J. Virol., August 1, 2007; 81(15): 7873 - 7884. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Deneka, A. Pelchen-Matthews, R. Byland, E. Ruiz-Mateos, and M. Marsh In macrophages, HIV-1 assembles into an intracellular plasma membrane domain containing the tetraspanins CD81, CD9, and CD53 J. Cell Biol., April 23, 2007; 177(2): 329 - 341. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gordon-Alonso, M. Yanez-Mo, O. Barreiro, S. Alvarez, M. A. Munoz-Fernandez, A. Valenzuela-Fernandez, and F. Sanchez-Madrid Tetraspanins CD9 and CD81 Modulate HIV-1-Induced Membrane Fusion J. Immunol., October 15, 2006; 177(8): 5129 - 5137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Sala-Valdes, A. Ursa, S. Charrin, E. Rubinstein, M. E. Hemler, F. Sanchez-Madrid, and M. Yanez-Mo EWI-2 and EWI-F Link the Tetraspanin Web to the Actin Cytoskeleton through Their Direct Association with Ezrin-Radixin-Moesin Proteins J. Biol. Chem., July 14, 2006; 281(28): 19665 - 19675. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Zieker, E. Fehrenbach, J. Dietzsch, J. Fliegner, M. Waidmann, K. Nieselt, P. Gebicke-Haerter, R. Spanagel, P. Simon, A. M. Niess, et al. cDNA microarray analysis reveals novel candidate genes expressed in human peripheral blood following exhaustive exercise Physiol Genomics, November 17, 2005; 23(3): 287 - 294. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-T. Zilber, N. Setterblad, T. Vasselon, C. Doliger, D. Charron, N. Mooney, and C. Gelin MHC class II/CD38/CD9: a lipid-raft-dependent signaling complex in human monocytes Blood, November 1, 2005; 106(9): 3074 - 3081. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Levy and T. Shoham Protein-Protein Interactions in the Tetraspanin Web Physiology, August 1, 2005; 20(4): 218 - 224. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. de la Fuente, M. Mittelbrunn, L. Sanchez-Martin, M. Vicente-Manzanares, A. Lamana, R. Pardi, C. Cabanas, and F. Sanchez-Madrid Synaptic Clusters of MHC Class II Molecules Induced on DCs by Adhesion Molecule-mediated Initial T-Cell Scanning Mol. Biol. Cell, July 1, 2005; 16(7): 3314 - 3322. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Tardif and M. J. Tremblay Tetraspanin CD81 Provides a Costimulatory Signal Resulting in Increased Human Immunodeficiency Virus Type 1 Gene Expression in Primary CD4+ T Lymphocytes through NF-{kappa}B, NFAT, and AP-1 Transduction Pathways J. Virol., April 1, 2005; 79(7): 4316 - 4328. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Barreiro, M. Yanez-Mo, M. Sala-Valdes, M. D. Gutierrez-Lopez, S. Ovalle, A. Higginbottom, P. N. Monk, C. Cabanas, and F. Sanchez-Madrid Endothelial tetraspanin microdomains regulate leukocyte firm adhesion during extravasation Blood, April 1, 2005; 105(7): 2852 - 2861. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Pfistershammer, O. Majdic, J. Stockl, G. Zlabinger, S. Kirchberger, P. Steinberger, and W. Knapp CD63 as an Activation-Linked T Cell Costimulatory Element J. Immunol., November 15, 2004; 173(10): 6000 - 6008. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Delaguillaumie, J. Harriague, S. Kohanna, G. Bismuth, E. Rubinstein, M. Seigneuret, and H. Conjeaud Tetraspanin CD82 controls the association of cholesterol-dependent microdomains with the actin cytoskeleton in T lymphocytes: relevance to co-stimulation J. Cell Sci., October 15, 2004; 117(22): 5269 - 5282. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Roda-Navarro, M. Mittelbrunn, M. Ortega, D. Howie, C. Terhorst, F. Sanchez-Madrid, and E. Fernandez-Ruiz Dynamic Redistribution of the Activating 2B4/SAP Complex at the Cytotoxic NK Cell Immune Synapse J. Immunol., September 15, 2004; 173(6): 3640 - 3646. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Mittelbrunn, A. Molina, M. M. Escribese, M. Yanez-Mo, E. Escudero, A. Ursa, R. Tejedor, F. Mampaso, and F. Sanchez-Madrid VLA-4 integrin concentrates at the peripheral supramolecular activation complex of the immune synapse and drives T helper 1 responses PNAS, July 27, 2004; 101(30): 11058 - 11063. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. D. Wright, S. M. Geary, S. Fitter, G. W. Moseley, L.-M. Lau, K.-C. Sheng, V. Apostolopoulos, E. G. Stanley, D. E. Jackson, and L. K. Ashman Characterization of Mice Lacking the Tetraspanin Superfamily Member CD151 Mol. Cell. Biol., July 1, 2004; 24(13): 5978 - 5988. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. van Spriel, K. L. Puls, M. Sofi, D. Pouniotis, H. Hochrein, Z. Orinska, K.-P. Knobeloch, M. Plebanski, and M. D. Wright A Regulatory Role for CD37 in T Cell Proliferation J. Immunol., March 1, 2004; 172(5): 2953 - 2961. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kobayashi, K. Ohnuma, M. Uchiyama, K. Iino, S. Iwata, N. H. Dang, and C. Morimoto Association of CD26 with CD45RA outside lipid rafts attenuates cord blood T-cell activation Blood, February 1, 2004; 103(3): 1002 - 1010. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |